У нас вы можете посмотреть бесплатно TFOS Dry Eye Workshop II Exec Summary, Drs. Craig and Nelson или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com Words matter! In this episode, Drs. Craig and Nelson describe the hurdles TFOS faced in arriving at the definition and the classification of dry eye disease. The group understood that revising the definition would require extreme care as it was to set the tone for work that followed. Drs. Craig and Nelson found that words truly do matter. Jennifer Craig, Ph.D., MSc, BSc (Hons), FCOptom, FAAO, FBLCA, FACLS is an associate professor at the University of Auckland, New Zealand, and Vice-Chair of TFOS DEWS II. J. Daniel Nelson, MD, was Chair of TFOS DEWS II and is a Senior Fellow at Health Partners Institute in Wyoming, Minnesota. About Our Sponsors ALCON Over 30 million people in the US suffer from dry eyes. 86% of dry eye patients have signs of MGD. The Systane® iLux® suite of three innovations embraces Alcon's dry eye suite to have the tools you need to help tackle MGD from start to finish. The Systane® iLux® MGD Thermal Pulsation System delivers treatment directly to the blocked meibomian glands with the goal of clearing any obstructions. Treatment of both eyes takes approximately 8–12 minutes. NOVALIQ Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free technology. Novaliq offers an industry-leading portfolio addressing today's unmet medical needs of millions of patients with eye diseases. Novaliq GmbH is headquartered in Heidelberg, Germany, and Novaliq Inc. has an office in Cambridge, MA, USA. The long-term shareholder is dievini Hopp BioTech holding GmbH & Co. KG, an active investor in Life and Health Sciences companies. More on www.novaliq.com. #dryeyes #optometry #ophthalmologist #tfos #tfosdewsii #eye research #ophthalmology #eye care #eye health